Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Long-Term Projected Growth Rate for the Eylea Market, and What Are the Key Drivers?

In recent times, the Eylea market has been registering consistent growth. It is expected to increase from $8.09 billion in 2024 to $8.49 billion in 2025, which signifies a compound annual growth rate (CAGR) of 4.9%. The expansion during the previous period has been credited to factors like the prevalence of diabetic macular edema (DME), proven clinical effectiveness and good safety records, competition with other anti-VEGF treatments, approval for diverse retinal conditions, and a trend towards intravitreal injections.

The eylea market is projected to experience substantial growth in the upcoming years. It is forecasted to develop to $10.75 billion by 2029 with a compound annual growth rate (CAGR) of 6.1%. The increased growth during the forecast period can be linked to a variety of factors such as the advent of new therapeutic indications, the launch of biosimilar competitors, growing consciousness and diagnoses, real-world evidence paired with post-market research, and patients preferring less frequent injections. Mainline trends during the predicted period involve advancements in imaging technology, telemedicine, remote monitoring, patient assistance programs, progress in drug delivery technologies, retinal imaging technologies and clinical trials for new indications.

Which Major Market Drivers Are Expected to Boost the eylea Market’s Growth Potential?

The Eylea market is projected to surge due to the rising occurrence of ocular diseases. These diseases affect the eye’s capacity to function efficiently, impairing vision clarity. Often, these conditions go unnoticed until they have significantly advanced. Eylea is a treatment for ocular diseases such as wet age-related macular degeneration (AMD) and glaucoma, conditions that harm the retina or macula and impair vision. The drug works by inhibiting a protein responsible for creating new, weaker blood vessels and slowing the inflammation of the retina due to obstructed blood vessels. For example, in October 2022, the BrightFocus Foundation, a nonprofit organization in the US devoted to macular degeneration and glaucoma research and support, reported that there were 80 million people worldwide suffering from glaucoma, projected to rise to over 111 million by 2040. Hence, the escalating incidences of ocular diseases are fueling the Eylea market.

Request Your Free Eylea Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=9155&type=smp

Who Are the Major Companies Shaping the Competitive Landscape of the Eylea Market?

Major companies operating in the eylea market include:

• Regeneron Pharmaceuticals Inc._x000D_

• Bayer AG_x000D_

• Novartis AG_x000D_

• Roche Holding AG_x000D_

• Pfizer Inc._x000D_

What Are the Key Emerging Trends in the Eylea Market for the Next Decade?

The focus on research and development is a prominent trend emerging in the eylea market. The primary aim for dominant participants in the eylea sector is to create advanced technological solutions. For example, in August 2023, Regeneron Pharmaceuticals, Inc., a biotechnology firm located in the US that is engaged in producing medicine for severe diseases, obtained approval from the US FDA for Eylea HD (aflibercept) injection 8 mg. This solution is designed to treat patients suffering from wet age-related macular degeneration (wAMD), diabetic macular edema (DME), and diabetic retinopathy (DR). The recommended protocol begins with an interval of every four weeks for the initial three months across all indications. This is succeeded by variable periods of every eight to 16 weeks for wAMD and DME, and every eight to 12 weeks for diabetic retinopathy.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/eylea-global-market-report

What Are the Major Segments of the Eylea Market and Their Role in Driving Growth?

The eylea market covered in this report is segmented –

1) By Product: Prefilled Syringe Package, Vial Package

2) By Disorder: Wet Age-Related Macular Degeneration (AMD), Diabetic Retinopathy, Other Disorders

3) By Application: Hospitals, Retail Pharmacy, Other Applications

Subsegments:

1) By Prefilled Syringe Package: Single-Dose Prefilled Syringes, Multi-Dose Prefilled Syringes

2) By Vial Package: Single-Dose Vials, Multi-Dose Vials

Which Regions Are Making a Mark in the Eylea Market Growth?

North America was the largest region in the eylea market in 2024. Asia-Pacific is expected to be the fastest-growing region in the eylea market during the forecast period. The regions covered in the eylea market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

How Is the Eylea Market Categorized and Defined in the Industry?

Eylea is a type of drug injected into the eye that helps slow vision loss and certain other diseases by blocking the leaking and growth of fluid from abnormal blood vessels from the back of the eye. It is used to treat age-related macular degeneration (AMD).

Browse Through More Similar Reports By The Business Research Company:

Network Engineering Services Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/network-engineering-services-global-market-report

Product Engineering Services Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/product-engineering-services-global-market-report

IoT in Manufacturing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/iot-in-manufacturing-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: